JPRN-UMIN000012862已完成未知
Efficacy and pharmacokinetics study of erlotinib in patients with non-small cell lung cancer - Efficacy and pharmacokinetics study of erlotinib in patients with non-small cell lung cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with interstitial pneumonitis identified by chest X-ray
研究者
相似试验
已完成
不适用
Evaluation of efficacy of erlotinib in patients with untreated, EGFR mutation positive, untreated-locally advanced NSCLC.ntreated, EGFR mutation positive, untreated-locally advanced NSCLC.JPRN-UMIN000011467agasaki Thoracic Oncology Group10
已完成
不适用
[11C]Erlotinib pharmacokinetics: an in vivo study using positron emission tomography in non-small cell lung cancer patients with and without erlotinib therapy.non-small cell lung carcinoma10038666lung cancerNL-OMON36826Vrije Universiteit Medisch Centrum10
尚未招募
2 期
To evaluate the efficacy and safety of Erlotinib and Bevacizumab in patients with advanced Non-squamous Non-Small Cell Lung Cancer with brain metastasis who acquired resistance to prior EGFR-TKI treatment harboring EGFR mutation.on-Small-Cell Lung CancerJPRN-UMIN000012515Department of Respiratory Medicine, Kumamoto University Hospital16
终止
1 期
Erlotinib Hydrochloride in Treating Non-Small Cell Lung Cancer That is Metastatic or Cannot be Removed by Surgery in Patients With HIV InfectionHIV InfectionRecurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung CancerNCT02134886National Cancer Institute (NCI)48
进行中（未招募）
不适用
Pharmacodynamic study of Erlotinib (Tarceva) in patients with mestastatic or locally advanced Epidermoid carcinoma of the head and neckMestastatic or locally advanced Epidermoid carcinoma of the head and neckEUCTR2005-003814-14-ESnidad Integral de Investigación en Oncología, S.L.49